Seroprevalence of hepatitis B and C and of human immunodeficiency virus among blood donors in south-west Nigeria

References

• Pillonel J, Le Marrec N, Girault A, David D, Laperche S. Epidemiological surveillance of blood donors and residual risk of blood-borne infections in France, 2001–2003. Transfus Clin Biol 2005; 12: 239–46.
   Google Scholar
• Ameen R, Sanad N, Al-Shemmari S et al. Prevalence of viral markers among first-time Arab blood donors in Kuwait. Transfusion 2005; 45: 1973–80.
   Google Scholar
• Singh B, Kataria SP, Gupta R. Infectious markers in blood donors of East Delhi: prevalence and trends. Indian J Pathol Microbiol 2004; 47: 477–9.
   Google Scholar
• Bashawari LA, Fawaz NA, Ahmad MS, Qadi AA, Almawi WY. Prevalence of sero-markers of HBV and HCV among blood donors in eastern Saudi Arabia, 1998–2001. Clin Lab Haematol 2004; 26: 225–8.
   Google Scholar
• Gonzalez M, Regine V, Piccinni V, Vulcano F, Giampaolo A, Hassan HJ. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus and hepatitis B virus infections in Italy. Transfusion 2005; 45: 1670–5.
   Google Scholar
• Ejele OA, Ojule AC. The prevalence of hepatitis B surface antigen (HBsAg) among prospective blood donors and patients in Port Harcourt, Nigeria. Niger J Med 2004; 13: 336–8.
   Google Scholar
• Soldan K, Barbara JA, Dow BC. Transfusion-transmitted hepatitis B virus infection in the UK: a small and moving target. Vox Sang 2002; 83: 305–8
   Google Scholar
• Khattak MF, Salamat N, Bhatti FA, Qureshi TZ. Sero-prevalence of hepatitis B, C and HIV in blood donors in northern Pakistan. J Pak Med Assoc 2002; 52: 398–402.
   Google Scholar
• Offergeld R, Ritter S, Faensen D, Hamouda O. HIV, HCV, HBV and syphilis infections among blood donors in Germany, 2003–2004. Report of the Robert Koch Institute in accordance with Article 22 of the Transfusion Act (German). Bundesgundheitblatt Gesundheitforschung Gesundheitsschutz 2005; 48: 1273–7.
   Google Scholar
• Dray X, Dray-Spira R, Bronstein JA, Mattera D. Prevalence of HIV, hepatitis B and hepatitis C in blood donors in the Republic of Djibouti (French). Med Trop (Mars) 2005; 65: 39–42.
   Google Scholar
• Halim NK, Ajayi OI. Risk factors and sero-prevalence of hepatitis C antibody in blood donors in Nigeria. East Afr Med J 2000; 77: 410–2.
   Google Scholar
• Jeannel D, Fretz C, Traore Y et al. Evidence for high genetic diversity and long-term endemicity of hepatitis C virus genotypes 1 and 2 in West Africa. J Med Virol 1998; 55: 92–7.
   Google Scholar
• Wansbrough-Jones M, Frimpong E, Cant B, Harris K, Evans M, Teo C. Prevalence and genotype of hepatitis C virus infection in pregnant women and blood donors in Ghana. Trans R Soc Trop Med Hyg 1998; 92: 496–9.
   Google Scholar
• Baidy Lo B, Meymouna M, Boulahi M et al. Prevalence des marqueurs seriques des virus des hepatitis Bet C ches les donneurs de sang Nouakchott, Mauritania. Bull Soc Pathol Exot 1999; 92: 83–4.
   Google Scholar
• Ghavanini AA, Sabri MR. Hepatitis B surface antigen and antihepatitis C antibodies among blood donors in the Islamic Republic of Iran. East Mediterr Health J 2000; 6: 1114–6.
   Google Scholar
• Luksamijarulkul P, Thammata N, Tiloklurs M. Sero-prevalence of hepatitis B, hepatitis C and human immunodeficiency virus among blood donors, Phitsanulok Regional Blood Center, Thailand. Southeast Asian J Trop Med Public Health 2002; 33: 272–9.
   Google Scholar
• Mutlu B, Meric M, Willke A. Sero-prevalence of hepatitis B and C virus, human immunodeficiency virus and syphilis in the blood donors (Turkish). Mikrobiyol Bul 2004; 38: 445–8.
   Google Scholar
• Otegbayo JA, Fasola FA, Abja A. Prevalence of hepatitis B surface and e antigens, risk factors for viral acquisition and serum transaminase among blood donors in Ibadan, Nigeria. Trop Gastroenterol 2003; 24: 196–7.
   Google Scholar
• Salomon JA, Weinstein MC, Hammitt JK, Goldie SJ. Empirically calibrated model of hepatitis C virus infection in the United States. Am J Epidemiol 2002; 156: 761–73.
   Google Scholar
• Ruggieri A, Argentini C, Kouruma F et al. Heterogeneity of hepatitis C virus genotype 2 variants in West Central Africa (Guinea Conakry). J Gen Virol 1996; 77: 2073–6.
   Google Scholar
• Hung K, Chen W, Yang C, Lee S, Wu D. Hepatitis B and C in haemodialysis patients. Nephrol Dial Transplant 1995; 24: 135.
   Google Scholar
• Tefanov V, Tallo T, Jaroslavtsev N, Priimgi L. Viral hepatitis B and C among injecting drug users in prisons and visitors of anonymous consulting rooms during the dramatic increase in HIV infections in Estonia. J Clin Virol 2003; 27: 62.
   Google Scholar
• Devi KS, Singh NB, Mara J, Singh TB, Singh YM. Seroprevalence of hepatitis B virus and hepatitis C virus among hepatic disorders and injecting drug users in Manipur: a preliminary report. Indian J Med Microbiol 2004; 22: 136–7.
   Google Scholar
• Idigbe EO. Surveillance of HIV/AIDS in Nigeria. 1st Scientific Summit, Network of African Science Academies, Abuja, Nigeria, September 2004.
   Google Scholar
• Inyamma U, Uneke PJ, Anyanwu CI, Njoku GM, Julia OHI. Prevalence of antibodies to hepatitis C virus among Nigerian patients with HIV infections. J Health Allied Sci 2005; 4: 1.
   Google Scholar
• Halim NKD, Offor E, Ajayi OI. Epidemiological study of the seroprevalence of hepatitis B surface antigen (HBsAg) and HIV-1 in blood donors. Niger J Clin Pract 1992; 2: 42–5.
   Google Scholar
• Adediran IA, Fasegun RB, Oyekunle AA. Haematological parameters in the prospective Nigerian blood donors rejected on account of anaemia and/or microfilaria infestation. Niger J Med 2005; 14: 45–50.
   Google Scholar
• Ikeh EI, Okeke FIO. Prevalence of malaria parasitaemia in screened blood donors at Jos University Teaching Hospital, Nigeria. Niger J Health Biomed Sci 2005; 4: 99–101.
   Google Scholar